塞拉斯生命科学 SLS
$8.42 +$0.54 (+6.85%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $8.33 -1.07%
开盘$8.03
昨收$7.88
当日区间$7.14 – $8.42
成交量7.62M
市值$1.70B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$10.63M-54.6% YoY
净利润-$9.61M-45.5% YoY
摊薄每股收益-$0.05+28.6% YoY
自由现金流-$7.59M-3.5% YoY
经营现金流-$7.59M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-39.6%
资产收益率-36.5%
投入资本回报率-42.6%
流动比率18.83
负债/资产比率5.3%
现金及投资$138.34M
总负债$157,000.00
净现金（净负债）$138.19M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $10.63M | $9.25M | $28.27M | $8.26M | $7.08M |
| 销售及管理费用 | $4.36M | $4.12M | $12.25M | $3.53M | $2.87M |
| -管理费用 | $4.36M | $4.12M | $12.25M | $3.53M | $2.87M |
| 研发费用 | $6.27M | $5.13M | $16.02M | $4.73M | $4.22M |
| 营业利润 | -$10.63M | -$9.25M | -$28.27M | -$8.26M | -$7.08M |
| 非经营性利息净收入（支出） | $1.02M | $845,000.00 | $1.41M | $597,000.00 | $292,000.00 |
| 非经营性利息收入 | $1.02M | $845,000.00 | $1.41M | $597,000.00 | $292,000.00 |
| 税前利润 | -$9.61M | -$8.41M | -$26.86M | -$7.66M | -$6.79M |
| 净利润 | -$9.61M | -$8.41M | -$26.86M | -$7.66M | -$6.79M |
| 持续经营利润 | -$9.61M | -$8.41M | -$26.86M | -$7.66M | -$6.79M |
| 归属母公司净利润 | -$9.61M | -$8.41M | -$26.86M | -$7.66M | -$6.79M |
| 归属普通股股东净利润 | -$9.61M | -$8.41M | -$26.86M | -$7.66M | -$6.79M |
| 基本每股收益 | -$0.05 | -$0.05 | -$0.25 | -$0.05 | -$0.06 |
| 摊薄每股收益 | -$0.05 | -$0.05 | -$0.25 | -$0.05 | -$0.06 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $145.38M | $114.18M | $78.35M | $78.35M | $51.56M |
| 流动资产合计 | $142.51M | $111.17M | $75.21M | $75.21M | $49.05M |
| 现金及现金等价物与短期投资 | $138.34M | $107.10M | $71.79M | $71.79M | $44.32M |
| -现金及现金等价物 | $138.34M | $107.10M | $71.79M | $71.79M | $44.32M |
| 预付资产 | $4.06M | $3.97M | $3.10M | $3.10M | $4.41M |
| 受限现金 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 |
| 非流动资产合计 | $2.88M | $3.01M | $3.13M | $3.13M | $2.50M |
| 固定资产净值 | $710,000.00 | $839,000.00 | $963,000.00 | $963,000.00 | $556,000.00 |
| -固定资产原值 | $710,000.00 | $839,000.00 | $963,000.00 | $963,000.00 | $556,000.00 |
| 商誉及其他无形资产 | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M |
| -商誉 | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M |
| 其他非流动资产 | $253,000.00 | $255,000.00 | $257,000.00 | $257,000.00 | $34,000.00 |
| 负债合计 | $7.73M | $6.77M | $7.47M | $7.47M | $5.93M |
| 流动负债合计 | $7.57M | $6.46M | $7.02M | $7.02M | $5.93M |
| 应付款 | $3.09M | $3.63M | $2.95M | $2.95M | $2.31M |
| -应付账款 | $3.09M | $3.63M | $2.95M | $2.95M | $2.31M |
| 一年内应计费用 | $2.69M | $1.61M | $1.73M | $1.73M | $1.57M |
| 短期债务及融资租赁负债 | $580,000.00 | $562,000.00 | $544,000.00 | $544,000.00 | $599,000.00 |
| -一年内到期融资租赁负债 | $580,000.00 | $562,000.00 | $544,000.00 | $544,000.00 | $599,000.00 |
| 其他流动负债 | $58,000.00 | $24,000.00 | $42,000.00 | $42,000.00 | $32,000.00 |
| 非流动负债合计 | $157,000.00 | $309,000.00 | $457,000.00 | $457,000.00 | $0.00 |
| 长期债务及融资租赁负债 | $157,000.00 | $309,000.00 | $457,000.00 | $457,000.00 | $0.00 |
| -长期融资租赁负债 | $157,000.00 | $309,000.00 | $457,000.00 | $457,000.00 | $0.00 |
| 股东权益合计 | $137.66M | $107.41M | $70.87M | $70.87M | $45.63M |
| 股东权益 | $137.66M | $107.41M | $70.87M | $70.87M | $45.63M |
| 股本 | $20,000.00 | $18,000.00 | $15,000.00 | $15,000.00 | $12,000.00 |
| -普通股 | $20,000.00 | $18,000.00 | $15,000.00 | $15,000.00 | $12,000.00 |
| 资本公积 | $430.64M | $390.79M | $345.84M | $345.84M | $312.95M |
| 留存收益 | -$293.00M | -$283.40M | -$274.99M | -$274.99M | -$267.33M |
| 其他流动资产 | – | – | $223,000.00 | $223,000.00 | $225,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$7.59M | -$8.85M | -$28.39M | -$4.92M | -$7.07M |
| 持续经营经营活动现金流净额 | -$7.59M | -$8.85M | -$28.39M | -$4.92M | -$7.07M |
| 持续经营净利润 | -$9.61M | -$8.41M | -$26.86M | -$7.66M | -$6.79M |
| 其他非现金项目 | $154,000.00 | $153,000.00 | $597,000.00 | $154,000.00 | $147,000.00 |
| 营运资金变动 | $848,000.00 | -$1.39M | -$4.08M | $2.14M | -$927,000.00 |
| -预付资产变动 | -$88,000.00 | -$652,000.00 | -$968,000.00 | $1.09M | -$635,000.00 |
| -应付账款及应计费用变动 | $1.10M | -$579,000.00 | -$2.48M | $1.21M | -$134,000.00 |
| -其他流动负债变动 | -$159,000.00 | -$159,000.00 | -$635,000.00 | -$159,000.00 | -$158,000.00 |
| 筹资活动现金流 | $38.83M | $44.15M | $86.30M | $32.39M | $26.09M |
| 持续经营筹资活动现金流净额 | $38.83M | $44.15M | $86.30M | $32.39M | $26.09M |
| 普通股发行净额 | $0.00 | $0.00 | $23.05M | $0.00 | $0.00 |
| 股票期权行使所得 | $38.83M | $44.15M | $63.77M | $32.92M | $26.09M |
| 期末现金余额 | $138.44M | $107.20M | $71.89M | $71.89M | $44.42M |
| 现金净变动 | $31.25M | $35.30M | $57.91M | $27.47M | $19.02M |
| 期初现金余额 | $107.20M | $71.89M | $13.99M | $44.42M | $25.40M |
| 自由现金流 | -$7.59M | -$8.85M | -$28.39M | -$4.92M | -$7.07M |
| 其他筹资费用净额 | – | – | -$527,000.00 | – | – |
暂无评论——快来第一个聊聊 SLS。
登录后参与讨论。